Vincenzo Tegazzin

In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low‐risk subjects

Helle Ørding, Virginia Brancadoro, Santolo Cozzolino et al. · Acta Anaesthesiologica Scandinavica · 1997 · 295 citations

Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.

Francesco Zorzato, Erica Scutari, Vincenzo Tegazzin et al. · PubMed · 1993 · 139 citations

Neurotransmitter, Intracellular Ca2+ Homeostasis, Neurotransmission +18

Identification of Novel Mutations in the Ryanodine-Receptor Gene (RYR1) in Malignant Hyperthermia: Genotype-Phenotype Correlation

Bernadette M. Manning, Kathleen A. Quane, Helle Ørding et al. · The American Journal of Human Genetics · 1998 · 134 citations · Full text

Malignant Hyperthermia, Molecular Physiology, Molecular Biology +4

Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility

Nicole Monnier, G. Kozak‐Ribbens, R Krivosic-Horber et al. · Human Mutation · 2005 · 126 citations

Genetic Testing, Genetics, Genetic Epidemiology +16

Recent advances in the diagnosis of malignant hyperthermia susceptibility: How confident can we be of genetic testing?

Rachel L. Robinson, Martin Anetseder, Virginia Brancadoro et al. · European Journal of Human Genetics · 2003 · 100 citations · Full text

Genetic Testing, Hyperthermia, Genetic Disorder +10